Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Verweij

Showing results (341-350 of 655) with videos related to

Pageof 66
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 12, 1999
Randomized study of a short course of weekly cisplatin with or without amifostine in advanced head and neck cancer. EORTC Head and Neck Cooperative GroupA S Planting, G Catimel, P H de Mulder, et al.
The American Journal of Tropical Medicine and Hygiene|April 9, 2014
Impact of short-time urine freezing on the sensitivity of an established Schistosoma real-time PCR assayHilaire M Kenguele, Ayola A Adegnika, Anne-Marie Nkoma, et al.
British Journal of Cancer|January 22, 2004
Factors affecting pharmacokinetic variability of oral topotecan: a population analysisF Léger, W J Loos, J Fourcade, et al.
Plos Neglected Tropical Diseases|October 29, 2019
Comparison of four DNA extraction and three preservation protocols for the molecular detection and quantification of soil-transmitted helminths in stoolMio Ayana, Piet Cools, Zeleke Mekonnen, et al.
Plos One|May 19, 2020
Within-patient plasmid dynamics in Klebsiella pneumoniae during an outbreak of a carbapenemase-producing Klebsiella pneumoniaeJoep J J M Stohr, Jaco J Verweij, Anton G M Buiting, et al.
Anti-Cancer Drugs|December 10, 1999
Phase I and pharmacologic study of BMS-181174 given as a 6 h infusion every 4 weeks to patients with advanced solid tumorsA S Planting, J H Schellens, M E van der Burg, et al.
British Journal of Cancer|May 1, 1996
Bioavailability and pharmacokinetics of oral topotecan: a new topoisomerase I inhibitorJ H Schellens, G J Creemers, J H Beijnen, et al.
Muscle & Nerve|June 1, 1997
Progression of paclitaxel-induced neuropathy following discontinuation of treatmentM J van den Bent, V J van Raaij-van den Aarssen, J Verweij, et al.
Microbial Genomics|July 29, 2025
Molecular characterization and prevalence of plasmids co-harbouring <i>mcr</i> and ESBL genesK M G Houkes, V Weterings, J J Verweij, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|June 29, 1999
Prediction of the systemic exposure to oral 9-amino-20(S)-camptothecin using single-sample analysisA Sparreboom, M J de Jonge, C J Punt, et al.
Pageof 66

Showing results (341-350 of 655) with videos related to

Sort By:
Pageof 66
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 12, 1999
Randomized study of a short course of weekly cisplatin with or without amifostine in advanced head and neck cancer. EORTC Head and Neck Cooperative GroupA S Planting, G Catimel, P H de Mulder, et al.
The American Journal of Tropical Medicine and Hygiene|April 9, 2014
Impact of short-time urine freezing on the sensitivity of an established Schistosoma real-time PCR assayHilaire M Kenguele, Ayola A Adegnika, Anne-Marie Nkoma, et al.
British Journal of Cancer|January 22, 2004
Factors affecting pharmacokinetic variability of oral topotecan: a population analysisF Léger, W J Loos, J Fourcade, et al.
Plos Neglected Tropical Diseases|October 29, 2019
Comparison of four DNA extraction and three preservation protocols for the molecular detection and quantification of soil-transmitted helminths in stoolMio Ayana, Piet Cools, Zeleke Mekonnen, et al.
Plos One|May 19, 2020
Within-patient plasmid dynamics in Klebsiella pneumoniae during an outbreak of a carbapenemase-producing Klebsiella pneumoniaeJoep J J M Stohr, Jaco J Verweij, Anton G M Buiting, et al.
Anti-Cancer Drugs|December 10, 1999
Phase I and pharmacologic study of BMS-181174 given as a 6 h infusion every 4 weeks to patients with advanced solid tumorsA S Planting, J H Schellens, M E van der Burg, et al.
British Journal of Cancer|May 1, 1996
Bioavailability and pharmacokinetics of oral topotecan: a new topoisomerase I inhibitorJ H Schellens, G J Creemers, J H Beijnen, et al.
Muscle & Nerve|June 1, 1997
Progression of paclitaxel-induced neuropathy following discontinuation of treatmentM J van den Bent, V J van Raaij-van den Aarssen, J Verweij, et al.
Microbial Genomics|July 29, 2025
Molecular characterization and prevalence of plasmids co-harbouring <i>mcr</i> and ESBL genesK M G Houkes, V Weterings, J J Verweij, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|June 29, 1999
Prediction of the systemic exposure to oral 9-amino-20(S)-camptothecin using single-sample analysisA Sparreboom, M J de Jonge, C J Punt, et al.
Pageof 66